Page 87 - Biennial Report 2018-20 Jun 2021
P. 87

58.    GBD 2017 SDG Collaborators. “Measuring progress from 1990 to 2017 and projecting
                         attainment  to  2030 of the health-related Sustainable Development Goals for 195
                         countries and territories: a systematic analysis for the Global Burden of Disease Study
                         2017.” LANCET 2018 Nov 10;392(10159):2091-2138.

                  59.    GBD 2017 Risk Factor Collaborators. “Global, regional, and national comparative risk
                         assessment of 84 behavioural, environmental and occupational, and metabolic risks or
                         clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for
                         the Global Burden of Disease Stu” LANCET 2018 Nov 10;392(10159):1923-1994.

                  60.    GBD 2017 Causes of  Death Collaborators.  “Global, regional, and national age-sex-
                         specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a
                         systematic analysis for the Global Burden of Disease Study 2017.” LANCET 2018 Nov
                         10;392(10159):1736-1788.

                  61.    GBD 2017  Mortality Collaborators.  “Global, regional, and national age-sex-specific
                         mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of
                         Disease Study 2017.” LANCET 2018 Nov 10;392(10159):1684-1735.
                  62.    GBD 2017  DALYs and HALE Collaborators.  “Global,  regional, and national disability-
                         adjusted life-years  (DALYs) for  359 diseases and injuries and healthy life expectancy
                         (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global
                         Burden of Disease Study 2017.” LANCET 2018 Nov 10;392(10159):1859-1922.
                  63.    Paliwal S, Chaudhuri R, Agrawal A, Mohanty S. “Human tissue-specific MSCs demonstrate
                         differential mitochondria  transfer abilities that may determine their  regenerative
                         abilities.” STEM CELL RES THER 2018 Nov 8;9(1):298.
                  64.    Kaur D, Mathew S, Nair CGS, Begum A, Jainanarayan AK, Sharma M, Brahmachari SK.
                         “Structure based drug discovery for designing leads for the non-toxic metabolic targets
                         in multi  drug resistant  Mycobacterium tuberculosis.”  J  TRANSL MED 2017  Dec
                         21;15(1):261.
                  65.    India State-Level Disease Burden Initiative CRD Collaborators. “The burden of chronic
                         respiratory diseases and their heterogeneity across the states of India: the Global Burden
                         of Disease Study 1990-2016.” LANCET GLOB HEALTH 2018 Dec;6(12):e1363-e1374.

                  66.    Sarkar P.G., Gupta M.D., Girish M.P., Bansal A, Kohli S, Saijpaul R, Tyagi S, Pasha Q.
                         “Tumor necrosis factor-alpha -308G/A gene polymorphism and novel biomarker profiles
                         in patients with  Takayasu arteritis.”  INDIAN HEART J 2018 Dec;70  Suppl 3(Suppl
                         3):S167-S172.

                  67.    Gupta M.D., Girish M.P., Sarkar P.G., Gupta A, Kategari A, Bansal A, Saijpaul R, Batra V,
                         Rain M,Tyagi S, Pasha Q.  “Role of ApoE gene polymorphism and nonconventional
                         biochemical risk factors  among very young individuals (aged less than  35 years)
                         presenting with acute  myocardial infarction.”  INDIAN HEART J  2018 Dec;70 Suppl
                         3(Suppl 3):S146-S156.
                  68.    Nisakar D, Vij M, Pandey T, Natarajan P, Sharma R, Mishra S and Ganguli M. “Deciphering
                         the Role of Chondroitin Sulfate in Increasing the Transfection Efficiency of Amphipathic
                         Peptide-Based Nanocomplexes” ACS Biomaterials Science & Engineering 2019 Jan  5(1):
                         45-55.



                                                           86
   82   83   84   85   86   87   88   89   90   91   92